CONGENITAL-MALFORMATIONS SURVEILLANCE - 2 AMERICAN-SYSTEMS
CONGENITAL-MALFORMATIONS SURVEILLANCE - 2 AMERICAN-SYSTEMS
复制标题
DOI：
10.1093/ije/10.3.247
复制
发表时间：
1981-01-01
影响因子：
7.7
通讯作者：
OAKLEY, GP
中科院分区：
文献类型：
--
作者：
EDMONDS, LD;LAYDE, PM;OAKLEY, GP
作为先天性畸形流行病学研究的一部分，疾病控制中心（CDC）在美国开展了2个出生缺陷监测系统。大都会亚特兰大先天缺陷计划（MACDP）是一个密集的监测系统，使用多种方法来识别亚特兰大地区出生缺陷的婴儿。出生缺陷监测方案是一个全国性的监测系统，每年监测100万名新生儿。占美国出生人口的1/3。它依靠新生儿出院摘要的诊断来确定受影响的婴儿。该系统最初设计用于检测在类似于沙利度胺的新致畸剂广泛传播后可能发生的出生缺陷的潜在流行。除了监测之外，它们也被证明是各种出生缺陷流行病学研究的有用资源。
As part of its epidemiologic studies of congenital malformations, the Centers for Disease Control (CDC) conducts 2 birth defects surveillance systems in the USA. The Metropolitan Atlanta Congenital Defects Program (MACDP) is an intensive surveillance system using several methods to identify infants born with birth defects in the Atlanta area. The Birth Defects Monitoring Program (BDMP) is a nationwide surveillance system that monitors 1 million births/yr, .apprx. 1/3 of all births in the USA. It relies on diagnoses from newborn discharge summaries to ascertain affected infants. The systems were originally designed to detect potential epidemics of birth defects that could occur following the widespread dissemination of new teratogens similar to thalidomide. In addition to monitoring, they have also proved to be useful resources for a variety of studies of the epidemiology of birth defects.